Profile
Daniel T.
Chiu is the founder of Cellectricon AB, founded in 2000, and MiCareo, Inc., founded in 2011.
Dr. Chiu currently holds the position of Independent Director at Fluicell AB since 2017 and has been a Professor at the University of Washington since 2006.
Dr. Chiu completed a doctorate degree at Harvard University and an undergraduate degree at Stanford University.
Daniel T. Chiu active positions
| Companies | Position | Start |
|---|---|---|
| FLUICELL AB | Director/Board Member | 2016-12-31 |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2009-10-28 |
Former positions of Daniel T. Chiu
| Companies | Position | End |
|---|---|---|
MiCareo, Inc.
MiCareo, Inc. BiotechnologyHealth Technology Provides tools for the analysis of rare cells | Founder | - |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Founder | - |
Training of Daniel T. Chiu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiCareo, Inc.
MiCareo, Inc. BiotechnologyHealth Technology Provides tools for the analysis of rare cells | Health Technology |
Fluicell AB
Fluicell AB BiotechnologyHealth Technology Provides fluid platforms for multi-functional pipettes for cell-based pharmacology research | Health Technology |
- Stock Market
- Insiders
- Daniel T. Chiu
















